1. Home
  2. ADX vs IDYA Comparison

ADX vs IDYA Comparison

Compare ADX & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adams Diversified Equity Fund Inc.

ADX

Adams Diversified Equity Fund Inc.

N/A

Current Price

$25.90

Market Cap

3.2B

Sector

Finance

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

SELL

Current Price

$38.26

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ADX
IDYA
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.6B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
ADX
IDYA
Price
$25.90
$38.26
Analyst Decision
Strong Buy
Analyst Count
0
14
Target Price
N/A
★ $52.75
AVG Volume (30 Days)
237.7K
★ 689.3K
Earning Date
01-01-0001
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.90
EPS
★ N/A
N/A
Revenue
N/A
★ $218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$191.41
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3024.43
52 Week Low
$20.91
$26.05
52 Week High
$26.56
$42.68

Technical Indicators

Market Signals
Indicator
ADX
IDYA
Relative Strength Index (RSI) 52.04 49.32
Support Level $25.72 $36.13
Resistance Level $26.39 $38.37
Average True Range (ATR) 0.26 1.47
MACD -0.00 -0.06
Stochastic Oscillator 68.30 56.01

Price Performance

Historical Comparison
ADX
IDYA

About ADX Adams Diversified Equity Fund Inc.

Adams Diversified Equity Fund Inc is a diversified investment company. It is an internally managed closed-end fund whose investment objectives are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. It invests a majority of its assets in very liquid S&P 500 stocks, and has broad flexibility in the selection of stocks, but maintains a sector-neutral approach. The fund has a diversified equity portfolio that consists of securities of companies from energy, consumer staples, information technology, financials, and other sectors.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: